Source: Healthcare Press (healthcarepress.net)
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Abbvie to record US$4 billion impairment charges on Stemcentrx assetsAbbvie Inc on Friday said https://bit.ly/2F9iUlb it will record an estimated US$4 billion in impairment charges related to the scrapping of its ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
AbbVie halts late-stage trial for lung cancer drug Rova-TREUTERS: AbbVie said on Wednesday it had halted enrollment for a late stage trial of Rova-T as a second-line therapy for advanced small-cell lung ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trialREUTERS: Johnson and Johnson said on Tuesday a combination therapy containing its blockbuster cancer drug Imbruvica significantly improved ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Roche buys US biotech Jecure in race for liver disease drugsSwiss drugmaker Roche is buying U.S.-based Jecure Therapeutics, joining Pfizer, Gilead Sciences and Novartis in pursuit of new drugs to treat ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Roche says Hemlibra effective in pivotal studyRoche's Hemlibra provided sustained bleed control in the largest pivotal study to date of children with a form of haemophilia, the Swiss drugmaker ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Novartis goes after Roche asthma medicine Xolair with new drugNovartis said it is pushing ahead with a late-stage study of its experimental drug ligelizumab after announcing the medicine outperformed Roche's ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Gilead Sciences to hire Roche executive O'Day as new CEO: sourceDrugmaker Gilead Sciences Inc will name Roche Holding AG executive Daniel O'Day as its new chief executive officer, according to a source familiar ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Gilead Sciences hires Roche executive Daniel O'Day as CEODrugmaker Gilead Sciences Inc will name Roche Holding AG executive Daniel O'Day as its new chief executive officer, according to a source familiar ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Gilead Sciences snares Roche veteran O'Day as CEODrugmaker Gilead Sciences Inc will name Roche Holding AG executive Daniel O'Day as its new chief executive officer, according to a source familiar ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Roche seeks to freshen up Kadcyla label amid biosimilar defenseRoche aims to broaden use of its Kadcyla breast cancer drug as the Swiss pharmaceuticals giant defends itself against rivals who are moving in ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »